Edition:
United Kingdom

Pluristem Therapeutics Inc (PSTI.OQ)

PSTI.OQ on NASDAQ Stock Exchange Capital Market

0.99USD
8:59pm GMT
Change (% chg)

$-0.05 (-5.10%)
Prev Close
$1.04
Open
$1.02
Day's High
$1.03
Day's Low
$0.98
Volume
83,530
Avg. Vol
41,845
52-wk High
$1.63
52-wk Low
$0.98

Chart for

About

Pluristem Therapeutics Inc. is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The Company's lead indications are critical limb ischemia (CLI), recovery after surgery for femoral neck fracture and acute radiation syndrome. Its... (more)

Overall

Beta: 0.11
Market Cap(Mil.): $145.24
Shares Outstanding(Mil.): 97.47
Dividend: --
Yield (%): --

Financials

  PSTI.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -0.32 -- --
ROI: -76.96 0.28 15.02
ROE: -81.32 0.94 16.60

Israel's Pluristem sees positive results from leg pain study

TEL AVIV Israel's Pluristem Therapeutics Inc, a developer of placenta-based stem cell products, said on Tuesday it had positive results from a mid-stage study of its therapy to treat leg pain known as intermittent claudication (IC).

12 Jun 2018

Israel's Pluristem sees positive results from leg pain study

TEL AVIV, June 12 Israel's Pluristem Therapeutics Inc, a developer of placenta-based stem cell products, said on Tuesday it had positive results from a mid-stage study of its therapy to treat leg pain known as intermittent claudication (IC).

12 Jun 2018

Earnings vs. Estimates